Cargando…
Response to “Etiology and Management of Bleeding during ECMO in a COVID-19 Patient”
Autores principales: | Hayakawa, Masaki, Matsumoto, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147564/ https://www.ncbi.nlm.nih.gov/pubmed/33487608 http://dx.doi.org/10.5551/jat.61747-R |
Ejemplares similares
-
Etiology and Management of Bleeding during ECMO in a COVID-19 Patient
por: Yamada, Shinya, et al.
Publicado: (2021) -
Re: Is number of chiasmata an etiological factor of male infertility?
por: Sarrate, Zaida, et al.
Publicado: (2014) -
Letter of response to comments on: Developing a risk assessment score for patients with cancer during COVID-19 pandemic: A war on two fronts
por: Indini, Alice, et al.
Publicado: (2020) -
Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome
por: Hayakawa, Masaki, et al.
Publicado: (2021) -
Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19
por: Yekedüz, Emre, et al.
Publicado: (2021)